Recent research on NAT10‐catalyzed ac4C modifications in immune dysregulation and tumor immunotherapy response has found that NAT10 is significantly upregulated in cervical cancer and is associated with poorer survival in cervical cancer patients. This evidence concerns the gene NAT10 and cervical carcinoma.